';
HomeServicesTest guideAbacavir - plasma
string(4) "5817"

Abacavir - plasma Refered Test

Back to main menu

Eurofins Biomnis code

ABACA

Synonyms

  • Triumeq®
  • Kivexa®
  • Trizivir®
  • Ziagen®

Clinic significance

HIV antiretroviral, nucleoside analogue, inhibits HIV 1 reverse transcriptase. Oral bioavailability of the order of 80 %, half-life of approximately 1hr30. Its uptake is not modified by the intake of food. Shows good meningeal diffusion. Possible hypersensitivity reactions during the first 6 weeks of treatment. All respiratory, skin or digestive symptoms require an urgent examination. Never represcribe after discontinuation due to intolerance. Risk of lactic acidosis in patients suffering from hepatopathy or obese patients.

Prenalytics

  • 3 mL
  • EDTA Plasma centrifuged immediately
  • FROZEN

Further information

  • Sample at TO (before intake) T1H and T3H (after intake)
    Enclose the specific clinical information form (R6-INTGB : Anti retroviral treatment)

Methodology

HPLC - High Performance Liquid Chromatography

Turnaround time

3 weeks


Pathologist(s) in charge
Refered Test
Specialty
Analytical Chemistry
Contact(s)
Dr Gilles PANTEIX
Dr Laurence PELLEGRINA
Phone(s)
+334 72 80 10 41
+334 72 80 23 05

Caption

Refered TestThe pre-analytical conditions and prices are defined on the basis of the requirements of the performing laboratory.

Mettez à jour votre navigateur pour consulter ce site